Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $45,602 | 13 | 86.7% |
| Travel and Lodging | $5,115 | 18 | 9.7% |
| Food and Beverage | $1,894 | 31 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $21,926 | 25 | $0 (2021) |
| Regeneron Pharmaceuticals, Inc. | $9,814 | 8 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $8,196 | 9 | $0 (2023) |
| Merck Sharp & Dohme LLC | $6,641 | 8 | $0 (2023) |
| Amarin Pharma Inc. | $5,774 | 6 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $186.38 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $28.97 | 1 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $25.10 | 2 | $0 (2024) |
| Medtronic Vascular, Inc. | $19.71 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.55 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($13.55) |
| 2023 | $9,286 | 12 | Regeneron Healthcare Solutions, Inc. ($8,196) |
| 2022 | $71.97 | 2 | Regeneron Pharmaceuticals, Inc. ($43.00) |
| 2021 | $13.74 | 1 | PFIZER INC. ($13.74) |
| 2019 | $12,071 | 15 | PFIZER INC. ($6,262) |
| 2018 | $14,062 | 16 | PFIZER INC. ($13,896) |
| 2017 | $17,093 | 15 | Regeneron Pharmaceuticals, Inc. ($9,771) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.55 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/09/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Consulting Fee | Cash or cash equivalent | $2,864.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/09/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Consulting Fee | Cash or cash equivalent | $2,864.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/09/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Consulting Fee | Cash or cash equivalent | $1,432.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 05/22/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $545.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $272.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $272.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/24/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Travel and Lodging | In-kind items and services | $169.86 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/24/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $98.80 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/24/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $83.74 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/24/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $48.24 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/22/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Travel and Lodging | In-kind items and services | $599.82 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/22/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Travel and Lodging | In-kind items and services | $35.25 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 04/03/2022 | Regeneron Pharmaceuticals, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $43.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 04/02/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/11/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/23/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/29/2019 | PFIZER INC. | ELIQUIS (Drug) | Consulting Fee | Cash or cash equivalent | $4,950.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/17/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 11/04/2019 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $542.19 | General |
| 11/04/2019 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $346.61 | General |
| 11/04/2019 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $231.04 | General |
| 11/04/2019 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $126.70 | General |
| 09/04/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/12/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $59.72 | General |
| Category: Hypertriglyceridemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 2,346 | 3,161 | $255,893 | $60,069 |
| 2022 | 12 | 2,496 | 3,381 | $237,563 | $52,306 |
| 2021 | 14 | 2,908 | 4,008 | $263,816 | $61,639 |
| 2020 | 13 | 2,560 | 3,583 | $218,688 | $49,670 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 181 | $50,244 | $12,200 | 24.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,404 | 2,054 | $62,707 | $12,058 | 19.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 110 | $34,795 | $10,183 | 29.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 41 | $24,044 | $5,481 | 22.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 57 | 59 | $18,980 | $5,242 | 27.6% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 145 | 146 | $14,026 | $2,880 | 20.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 28 | $10,879 | $2,820 | 25.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 41 | $8,988 | $2,523 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $8,906 | $2,371 | 26.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 372 | 396 | $12,166 | $2,238 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 28 | $5,433 | $1,213 | 22.3% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 54 | 54 | $4,725 | $859.63 | 18.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,537 | 2,231 | $69,161 | $13,048 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 163 | $45,314 | $11,002 | 24.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 116 | $35,032 | $9,088 | 25.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 25 | $14,600 | $3,771 | 25.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 483 | 516 | $15,996 | $2,841 | 17.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 35 | 35 | $10,850 | $2,808 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $11,281 | $2,169 | 19.2% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2022 | 108 | 109 | $10,355 | $1,957 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 41 | $8,036 | $1,564 | 19.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 28 | $5,880 | $1,539 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $4,656 | $1,231 | 26.4% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 65 | 66 | $5,742 | $1,191 | 20.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $660.00 | $97.87 | 14.8% |
About Dr. Ross Simpson, MD
Dr. Ross Simpson, MD is a Cardiovascular Disease healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972678720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ross Simpson, MD has received a total of $52,611 in payments from pharmaceutical and medical device companies, with $13.55 received in 2024. These payments were reported across 62 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($45,602).
As a Medicare-enrolled provider, Simpson has provided services to 10,310 Medicare beneficiaries, totaling 14,133 services with total Medicare billing of $223,683. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Chapel Hill, NC
- Active Since 11/21/2006
- Last Updated 06/20/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1972678720
Products in Payments
- ELIQUIS (Drug) $10,580
- PRALUENT ALIROCUMAB INJECTION (Biological) $9,771
- CELEBREX (Drug) $8,409
- EVKEEZA (Biological) $8,239
- Vascepa (Drug) $5,774
- JARDIANCE (Drug) $90.43
- LEQVIO (Drug) $28.97
- LifeVest (Device) $25.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Chapel Hill
Kirkwood Adams, Md, MD
Cardiovascular Disease — Payments: $47,269
Dr. Leonard Gettes, Md, MD
Cardiovascular Disease — Payments: $18,815
Dr. George Stouffer, Md, MD
Cardiovascular Disease — Payments: $7,500
Dr. Patricia Chang, Md, MD
Cardiovascular Disease — Payments: $3,889
Dr. Alan Hinderliter, Md, MD
Cardiovascular Disease — Payments: $2,467
Dr. Michael Cowherd, Md, MD
Cardiovascular Disease — Payments: $2,286